005690 — Pharmicell Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Pharmicell Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	18,575	25,849	36,244	25,953	14,019
Net Total Accounts Receivable
Net Total Receivables	7,209	10,290	9,603	11,979	7,811
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	34,653	42,939	65,041	62,363	43,166
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	17,903	16,948	19,476	36,838	40,722
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	63,266	69,744	94,333	112,694	92,519
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	5,527	6,508	24,943	28,546	7,763
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	11,747	12,639	30,462	32,982	12,122
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	51,519	57,105	63,871	79,712	80,397
Total Liabilities & Shareholders' Equity	63,266	69,744	94,333	112,694	92,519
Total Common Shares Outstanding